SUBSCRIBE:
Loading ...Minnesota Viking Chris Kluwe spends a day in a wheelchair to support our efforts to pass the Jablonski Rodreick SCI TBI Research Bill. Continue Reading »
Spinal cord injury research at the University of British Columbia and Vancouver Coastal Health will be accelerated by a 10-year, $20 million contribution from the Rick Hansen Foundation.
The International Collaboration on Repair Discoveries (ICORD), a UBC-VCH research centre, will share the funds with the Rick Hansen Institute, which coordinates and assists spinal cord injury researchers around the world. Continue Reading »
Acorda Therapeutics said today it won a $2.67 million contract from the U.S. Army Medical Research and Material Command (USAMRMC) to support development of AC105 as a treatment for acute spinal cord injury (SCI).
The contract will help fund a Phase II clinical trial designed primarily to assess the safety and tolerability of AC105 in patients with acute SCI. The company plans to open enrollment for this study in the first half of this year. Continue Reading »
January 23, 2013 – Doctors at The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, performed the first-ever Food and Drug Administration approved Schwann cell transplantation in a patient with a new spinal cord injury. The procedure, performed at the University of Miami/Jackson Memorial Medical Center, is a Phase 1 clinical trial designed to evaluate the safety and feasibility of transplanting the patient’s own Schwann cells.
“This historic clinical trial represents a giant step forward in a field of medicine where each tangible step has tremendous value. This trial, and these first patients in this trial specifically, are extremely important to our mission of curing paralysis,” said neurosurgeon Barth Green, M.D., Co-Founder and Chairman of The Miami Project, and Professor and Chair of Neurological Surgery. Continue Reading »
A Big Opportunity – For Everyone
Spinal Cord Injury (SCI) refers to an injury to the spinal cord that is caused by direct trauma or secondary damage to the surrounding bone, tissue, or blood vessels. Classification of the extent of the injury is based on neurological responses, touch and pinprick sensations tested in each dermatome (an area of the skin supplied by a single spinal nerve), and strength of ten key muscles on each side of the body, including the hip flexion (L2), shoulder shrug (C4), elbow flexion (C5), wrist extension (C6), and elbow extension (C7). The four categories of SCI classification and their respective percent of the market are: Complete Tetraplegia (16%), Incomplete Tetraplegia (41%), Complete Paraplegia (22%), and Incomplete Paraplegia (21%) Continue Reading »
NSI-566 to be tested in patients with chronic spinal cord injury
ROCKVILLE, Md., Jan. 14, 2013 /PRNewswire/ – Neuralstem, Inc. (NYSE MKT: CUR) announced that it received approval from the United States Food and Drug Administration (FDA) to commence a Phase I safety trial of its lead cell therapy candidate, NSI-566, in chronic spinal cord injury patients. This open-label, multi-site study, will enroll up to eight patients with thoracic spinal cord injuries (T2-T12), who have an American Spinal Injury Association (AIS) A level of impairment, between one and two years after injury. AIS A impairment refers to a patient with no motor or sensory function in the relevant segments at and below the injury, and is considered to be complete paralysis. Continue Reading »
Systemic hypothermia remains a promising neuroprotective strategy. There has been recent interest in its use in patients with spinal cord injury (SCI). In this article, we describe our extended single center experience using intravascular hypothermia for the treatment of cervical SCI. Continue Reading »
This week’s Wee Answer Wednesday will be squarely focused on incontinence after a spinal cord injury. In the immediate aftermath of a spinal cord injury, there’s a lot to take in. Your life has changed in so many ways that it can be a challenge to get a handle on all the information coming your way. Some problems are bigger than others. In a recent survey of paralyzed veterans, incontinence was identified as the #2 most important issue for those in wheelchairs.
So whether you’re new to the issue or an old hat at managing your incontinence, here are some of the most common incontinence questions men ask after a spinal cord injury. Continue Reading »
LOUISVILLE, Ky. (Sept. 5, 2012) — Research studies from teams headed by a University of Louisville/Frazier Rehab Institute neuroscientist published online this week demonstrate for the first time that innovative rehabilitative treatments for individuals with spinal cord injuries (SCI) can lead to significant functional improvements in patients and a higher quality of life.
Eleven studies published in the September issue of the “Archives of Physical Medicine and Rehabilitation” conclude that establishing a network of rehab centers for SCI that standardizes treatment can lead to significant functional improvements for chronically injured patients. Continue Reading »
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
The online version of the supplement is available free to the public. The focus of this special supplement, which was spearheaded by Dr. Michael Fehlings, Professor of Neurosurgery at the University of Toronto and Medical Director of the Krembil Neuroscience Centre at the Toronto Western Hospital, is the development of cutting-edge translational research in the treatment of spinal cord injury (SCI), an often devastating injury that affects 2.5 million people worldwide, many of whom are first faced with it in early adulthood. The topic is addressed in a variety of forms in 17 articles and several editorials. Continue Reading »